Comparison among fertility-sparing therapies for well differentiate early-stage endometrial carcinoma and complex atypical hyperplasia.

about

Comparison among fertility-sparing therapies for well differentiate early-stage endometrial carcinoma and complex atypical hyperplasia.

Item

http://www.wikidata.org/entity/Q36376499

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Comparison among fertility-spa ...... complex atypical hyperplasia.

@ast

Comparison among fertility-spa ...... complex atypical hyperplasia.

@en

type

Item

label

Comparison among fertility-spa ...... complex atypical hyperplasia.

@ast

Comparison among fertility-spa ...... complex atypical hyperplasia.

@en

prefLabel

Comparison among fertility-spa ...... complex atypical hyperplasia.

@ast

Comparison among fertility-spa ...... complex atypical hyperplasia.

@en

P1476

Comparison among fertility-spa ...... complex atypical hyperplasia.

@en

P2093

Baoxia Cui

http://www.w3.org/2001/XMLSchema#string

Beihua Kong

http://www.w3.org/2001/XMLSchema#string

Gonghua Qi

http://www.w3.org/2001/XMLSchema#string

Margaux J Kanis

http://www.w3.org/2001/XMLSchema#string

Qing Zhang

http://www.w3.org/2001/XMLSchema#string

Ruifen Dong

http://www.w3.org/2001/XMLSchema#string

Xingsheng Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Forest plots: trying to see the wood and the trees

Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women

Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.

Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis.

Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia.

Levonorgestrel-impregnated intrauterine device as treatment for endometrial hyperplasia: a national multicentre randomised trial.

Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.

Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome.

Endometrial cancer in women 40 years old or younger.

Methodological index for non-randomized studies (minors): development and validation of a new instrument.

P31

scholarly article

P356

10.18632/ONCOTARGET.17588

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2017-05-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28525380

http://www.w3.org/2001/XMLSchema#string

28915701

http://www.w3.org/2001/XMLSchema#string

P932

5593673

http://www.w3.org/2001/XMLSchema#string